ATRC Oct 2024 25.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Is AtriCure, Inc. (NASDAQ:ATRC) Trading At A 48% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, AtriCure fair value estimate is US$39.98 Current share price...
- GuruFocus.com
Insider Buying: Chief Technical Officer Salvatore Privitera Acquires Shares of AtriCure Inc (ATRC)
On May 30, 2024, Salvatore Privitera, Chief Technical Officer of AtriCure Inc (NASDAQ:ATRC), purchased 5,000 shares of the company, as reported in a recent SEC Filing.
- Business Wire
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
MASON, Ohio, May 15, 2024--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Leerink Partners Healthcare Crossroads Conference.
© 2024 Yahoo. All rights reserved.